These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 652202)

  • 1. Erroneous clinical diagnosis of leg vein thrombosis in women on oral contraceptives.
    Barnes RW; Krapf T; Hoak JC
    Obstet Gynecol; 1978 May; 51(5):556-8. PubMed ID: 652202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should the pill be stopped preoperatively?
    Sue-Ling H; Hughes LE
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):447-8. PubMed ID: 3126855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism.
    Bennet L; Odeberg H
    J Intern Med; 1998 Jul; 244(1):27-32. PubMed ID: 9698021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies.
    Girolami A; Zanon E; Zanardi S; Saracino MA; Simioni P
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):497-501. PubMed ID: 8840004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the birth control pill and its relationship to thrombophlebitis.
    Julsrud ME
    J Am Podiatry Assoc; 1979 Jun; 69(6):376-82. PubMed ID: 448035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden: should we screen oral contraceptive users and pregnant women?
    Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR
    BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
    Realini JP; Encarnacion CE; Chintapalli KN; Rees CR
    J Am Board Fam Pract; 1997; 10(5):315-21. PubMed ID: 9297655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical embolism associated with oral contraceptives: an underdiagnosed lesion?
    de Swiet J
    Postgrad Med J; 1979 Jun; 55(644):419-20. PubMed ID: 482190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and venous thromboembolism: a quantitative discussion of the uncertainties.
    Koster T; Small RA; Rosendaal FR; Helmerhorst FM
    J Intern Med; 1995 Jul; 238(1):31-7. PubMed ID: 7608644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives, venous thrombosis, and varicose veins. Royal College of General Practitioners' Oral Contraception Study.
    J R Coll Gen Pract; 1978 Jul; 28(192):393-9. PubMed ID: 702453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
    Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
    Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases.
    Beaumont V; Lemort N; Beaumont JL
    Eur Heart J; 1991 Nov; 12(11):1219-24. PubMed ID: 1782953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptive use before and after the latest pill scare in The Netherlands. Changes in oral contraceptive use and how users change.
    de Vries CS; van den Berg PB; de Jong-van den Berg LT
    Contraception; 1998 Apr; 57(4):247-9. PubMed ID: 9649916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of thrombosis due to oral contraceptives: a further report.
    Maguire MG; Tonascia J; Sartwell PE; Stolley PD; Tockman MS
    Am J Epidemiol; 1979 Aug; 110(2):188-95. PubMed ID: 463873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive choices in women with coagulation disorders.
    Comp PC; Zacur HA
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.